Does second generation n-butyl cyanoacrylate embolization really smooth in greater saphenous vein closure?

Yilmaz S., Kiziltan F., Zengin S., Kalender M., ÇAM İ.

ARYA ATHEROSCLEROSIS, cilt.18, 2022 (ESCI) identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 18
  • Basım Tarihi: 2022
  • Doi Numarası: 10.22122/arya.v18i0.2374
  • Dergi Adı: ARYA ATHEROSCLEROSIS
  • Derginin Tarandığı İndeksler: Emerging Sources Citation Index (ESCI), Scopus, Academic Search Premier, EMBASE, Directory of Open Access Journals
  • Anahtar Kelimeler: Cyanoacrylate, Embolization, Thrombophlebitis, 1ST HUMAN USE, RADIOFREQUENCY ABLATION, LASER-ABLATION, INSUFFICIENCY, ADHESIVE, GLUE
  • Kocaeli Üniversitesi Adresli: Evet

Özet

BACKGROUND: Cyanoacrylate (CA) has been used as an embolizing agent in the treatment of greater saphenous vein (GSV) insufficiency in recent years and the results regarding the use of this method have started to be published. To the best of our knowledge, the publications in literature do not mention about a significant negative effect of endovenous CA (EVCA) embolization. We aimed to evaluate the effects and undesirable events of this relatively new treatment method and compare them with literature, using the follow-up data of our patients.